Undisclosed anti-mPD1-MDNA213
/ Medicenna
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
April 17, 2023
Medicenna Presents Preclinical IL-13 Superkine Data at the AACR Annual Meeting
(GlobeNewswire)
- "Anti-mPD1-MDNA213: In vitro data demonstrate that this BiSKIT retains strong binding affinity for both IL-13Rα2 and PD1, effectively blocks the PD1/PD-L1 interaction with similar potency as the native anti-PD1 antibody, allowing its activity to be localized in the TME."
Preclinical • Oncology
1 to 1
Of
1
Go to page
1